Phase I/II study of docetaxel/nedaplatin/5-FU for advanced esophageal cancer
Not Applicable
- Conditions
- Esophageal cancer
- Registration Number
- JPRN-UMIN000006615
- Lead Sponsor
- Chiba University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1) other active cancers 2) patients who want to be pregnant or pregnant woman 3)severe pshychological disorder 4) prior or current history of steroidal treatments 5) HBsAG(+) 6) Severe DM 7) History of Severe complications 8) History of cardiac infarction 9)Acative infection 10)inappropriate cases for a clinical trials
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method